Articles: list
France BioLead
What is France BioLead?
Join us
Members
Team
The Observatory of the Sector
Events
News
France BioLead news
News of the sector
Agenda
Future talents
Business Place
Manufacturing Active Substance
Aseptic Filling
Partnership opportunities
Health Technology Transfer
Join the platform
fr
en
France BioLead news
Trier par :
Loading
Clear all filters
France BioLead 2025 Activity Report
July 24, 2026
In 2025, France BioLead reached a new milestone by further strengthening the structure of France's biopharmaceutical manufacturing sector.
ACTUALITE FRANCE BIOLEAD
0
0
In Vivo CAR Therapy Workshop
July 23, 2026
France BioLead and UNITC, in collaboration with RIBB and PEPR, are pleased to invite you to their next In Vivo CAR Workshop on 2026 September 24, in Paris.
EVENEMENTS
ACTUALITE FRANCE BIOLEAD
THERAPIE CELLULAIRE
0
0
Biomedicine Bioproduction in Video
July 1, 2026
Biomedicines are at the heart of today’s major medical breakthroughs. But do you really know how they are designed, produced… and by whom? With the high school kit developed by France BioLead, dive into a fascinating world where biology, innovation, and cutting-edge technologies come together.
FORMATION & ENSEIGNEMENT
ACTUALITE FRANCE BIOLEAD
0
0
In La Rochelle, Calipso Sensors Prepares to Scale Up Production of Sensors for Biopharmaceutical Manufacturing
June 24, 2026
"The young company aims to mass-produce a new generation of sensors designed for biopharmaceutical manufacturing. The project is supported by the French government and key players in France's biomanufacturing sector."
ACTUALITE FRANCE BIOLEAD
0
0
Laurent Lafferrère (France BioLead): “Biotherapies account for 60% of medicines currently in development.”
June 18, 2026
Harnessing living systems to treat living patients: this principle underpins the rapid growth of biomedicines in recent years, a momentum that has accelerated in France since 2021 through France BioLead. The organization brings together all stakeholders across the sector. Competitiveness, attractiveness, and sovereignty are among the major challenges ahead. Laurent Lafferrère, President of the association, provides an overview of a sector that aims to establish itself as a strategic pillar.
ACTUALITE FRANCE BIOLEAD
0
0
National sovereign roadmap proposal for in vivo CARs
June 8, 2026
In vivo CAR therapies could well represent the next revolution in immunotherapy. While current CAR-T therapies have demonstrated their effectiveness, they remain complex, expensive, and difficult to deploy on a large scale. In contrast, in vivo CAR therapies offer a much simpler approach: directly programming a patient’s immune cells within the body, without the lengthy ex vivo manufacturing process.
ACTUALITE FRANCE BIOLEAD
THERAPIE CELLULAIRE
0
0
Teaching Guide on Biotechnology & Bioproduction for Year 11 teachers
June 5, 2026
The aim of this guide is to enable any teacher to get to grips with and lead the teaching modules on biotechnology and bioproduction. It provides a simple lesson plan, the key messages to convey, and practical tips for using the content in the classroom.
FORMATION & ENSEIGNEMENT
EMPLOI & STAGES
0
0
Biotech and bioproduction are just as strategic as defence,’ says Laurent Lafferrère, CEO of France Biolead
June 4, 2026
"Three years after the creation of France Biolead, which brings together all stakeholders in biomedicines across the country, CEO Laurent Lafferrère believes the sector has now become more unified. However, funding, public support, and European-level coordination are still lacking to accelerate progress in this strategic field of innovative, living-derived medicines that are at the forefront of treating serious diseases and rare conditions."
ACTUALITE FRANCE BIOLEAD
0
0
The French biopharmaceutical bioproduction sector is seeking greater attractiveness.
June 3, 2026
“In a context of declining attractiveness in research, France Biolead is aligning ideas to restore it, encouraging the creation of consortia to develop French innovations, and putting forward proposals to amend the Biotech Act.”
ACTUALITE FRANCE BIOLEAD
0
0
Contexte - Health Briefing: Biotech Regulation
June 3, 2026
"FR·EU | France BioLead Pushes for Greater Health Sovereignty and Competitiveness in EU Regulation"
ACTUALITE FRANCE BIOLEAD
0
0
🦠 Guide "Les super pouvoirs du vivant" 🦠
June 3, 2026
Behind every biopharmaceutical, there are people who have chosen to change lives. What if it were you? To make the world of biopharmaceutical production more accessible, France BioLead and Leem have designed this new educational kit especially for secondary school pupils.
FORMATION & ENSEIGNEMENT
ACTUALITE FRANCE BIOLEAD
EMPLOI & STAGES
0
0
Biopharmaceuticals: Calipso Sensors to Create 20 Jobs and Prepare for the Construction of a Manufacturing Plant
June 2, 2026
Calipso Sensors, a manufacturer of sensors for the biopharmaceutical industry, was founded last year in Périgny. The company emerged from a research project involving both public and private partners. Its goal is to create 20 jobs by 2028 and then build a factory in Sainte-Soulle, employing 50 people.
ACTUALITE FRANCE BIOLEAD
0
0
France/Canada: geopolitics puts industrial resilience back at the forefront
June 2, 2026
The restructuring of pharmaceutical supply chains, driven by current geopolitical tensions and lessons learned from the Covid-19 crisis, is pushing ecosystems to strengthen their bioproduction capacities. During a panel organized by France Biolead, industry players and institutional representatives outlined the contours of a closer relationship between the two countries, focusing on issues of sovereignty, competitiveness, and preparedness for health crises.
ACTUALITE FRANCE BIOLEAD
0
0
In La Rochelle, Calipso Sensors Prepares the Industrialization of Its Sensors for Biopharmaceuticals
June 1, 2026
'The young company aims to mass-produce a new generation of sensors designed for the manufacturing of biopharmaceuticals. The project is supported by the French government and key stakeholders in France’s biomanufacturing sector.'
ACTUALITE FRANCE BIOLEAD
0
0
France x Canada Panel – Unlocking Synergies in Biomanufacturing
May 20, 2026
Bioproduction, a strategic driver of not only health sovereignty but also industrial, technological and economic sovereignty, also requires a commitment to cooperation. This is why France BioLead has made Canada the guest of honour at JNBB 2026, with the aim of laying the foundations for practical collaboration. Watch the panel discussion
EVENEMENTS
ACTUALITE FRANCE BIOLEAD
0
0
Strategic overviews of bioproduction, for members only
April 17, 2026
Are you a member of France BioLead? Access all the sector overviews dedicated to antibodies and recombinant proteins, cell therapies, extracellular vesicles, viral vectors, RNA and nanoparticle vectorisation.
TECHNOLOGIES INNOVANTES
ACTUALITE FRANCE BIOLEAD
0
0
France is a country renowned for scientific excellence, but our public health sovereignty remains fragile
April 1, 2026
As France prepares to host the One Health Summit in Lyon from 5 to 7 April, several leaders of research institutes, universities and innovation hubs are calling for medical research to be made a central pillar of France’s health sovereignty.
0
0
Joint sectoral project: rolling out a national CAR in vivo pathway
March 31, 2026
A major project is taking shape for the biopharmaceutical production sector, spearheaded by France BioLead and UNITC: to develop a national strategy for the development of in vivo CARs in France. Would you like to find out more? Contact Alexis Behra a.behra@france-biolead.fr Translated with DeepL.com (free version)
EVENEMENTS
ACTUALITE FRANCE BIOLEAD
0
0
Biotech Act Webinar: Consultation with France BioLead members
March 17, 2026
The proposed “Biotech Act” regulation was submitted on 15 December 2025. It has not yet been voted on and will now go through the standard European legislative process (Parliament/Council), with likely amendments. This is an opportunity for the French biopharmaceutical production sector to make its voice heard. We are delighted to invite you to our France BioLead member consultation webinar on Tuesday 7 April at 1.15 pm
ACTUALITE FRANCE BIOLEAD
0
0
White paper "Towards of new era of intelligente bioproduction"
March 11, 2026
Towards "smart" bioproduction AI is changing the game in bioproduction: it is no longer just a tool, but a strategic lever to better control processes, accelerate developments, and improve the quality of biopharmaceuticals. The white paper provides a clear vision of this shift towards data-driven processes, serving industrial performance and sovereignty. Download the white paper https://whitepaper-ia.france-biolead.fr/eng
0
0
77
1
2
3
4
